Review

Bladder cancer epidemiology in the world and in Tukey
  • Sultan Eser
  • Raziye Özdemir
Bull Urooncol 2012; 11: 1-9
In which fields intermittent androgen deprivation therapy can be used in 2014?
  • Yasin Ceylan
  • Bu¨lent Gu¨nlu¨soy
Bull Urooncol 2014; 13: 33-36
Immunotherapy in prostate cancer
  • Murat Lekili
Bull Urooncol 2011; 10: 82-84
Society of Urooncology nomogram for kidney cancer – the user's manual
  • Özgür Yaycioglu
Bull Urooncol 2013; 12: 151-154
The significance of tertiary Gleason pattern in prostate cancer
  • H. Hüseyin Tavukçu
  • Polat Türker
Bull Urooncol 2012; 11: 168-172

Original Articles

The Effect of Tumor Size on Oncologic Outcomes in Pathological T2 Stage Renal Cell Carcinoma Patients
  • Dr. Nurullah Hamidi
  • Dr. Evren Süer
  • Dr. Ilker Gökçe
  • Dr. Yasar Bedük
  • Dr. Sümer Baltaci
Bull Urooncol 2017; 16: 1-3 DOI: 10.4274/uob.780
The Efficiency of Docetaxel Chemotherapy on Castration Resistant Prostate Cancer: Singe Center Experience
  • Evren Süer
  • Nurullah Hamidi
  • Mehmet Ilker Gökçe
  • Sümer Baltaci
Bull Urooncol 2017; 16: 77-80 DOI: 10.4274/uob.821
Survival and the Factors of Predict Survival in Non-Clear Cell Renal Cell Carcinoma Cases Which Have Been Undergone Nephron Sparing Surgery
  • Nurullah Hamidi
  • Evren Süer
  • Mehmet Ilker Gökçe
  • Sümer Baltaci
  • Yasar Bedük
Bull Urooncol 2015; 14: 79-82 DOI: 10.4274/uob.214

Case Report

A Rare Tumor: Prostate Neuroendocrine Carcinoma Case Report
  • Dr. Esref Oguz Güven
  • Dr. Numan Yikilmaz
  • Dr. Erdem Öztürk
  • Dr. Erman Damar
  • Dr. Halil Basar
Bull Urooncol 2017; 16: 31-33 DOI: 10.4274/uob.722

Medical Oncology

Neoadjuvant chemotherapy in muscle invasive bladder cancer
  • Evren Süer
  • Kadir Türkölmez
Bull Urooncol 2012; 11: 74-78

About Journal

Forms

Useful Links

Applications